Wecare Calasoothe — Class II drug recall D-0213-2026
Ongoing recall by Blossom Pharmaceuticals, reported 2025-12-10, distributed nationwide. cGMP deviations
| Recall number | D-0213-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Blossom Pharmaceuticals, Bardej, Goa, India |
| Recall initiated | 2025-10-31 |
| Classified | 2025-12-02 |
| Reported by FDA | 2025-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 2,400 containers |
| Reason classes | cgmp |
| NDC | 67777-0234, 67777-0234-01, 67777-0234-02, 67777-0234-03, 67777-0234-04 |
| Lot numbers | A482305 |
Product
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
Reason for recall
cGMP deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0213-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.